Sivik Global Healthcare LLC Seagen Inc. Transaction History

Sivik Global Healthcare LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$127.59 - $203.08 $382,770 - $609,240	3,000 Added 23.08%	16,000 $3.24 Million
Q4 2022 Feb 08, 2023	BUY	$117.37 - $139.17 $352,110 - $417,509	3,000 Added 30.0%	13,000 $1.67 Million
Q2 2022 Aug 10, 2022	SELL	$108.81 - $179.33 $816,075 - $1.34 Million	-7,500 Reduced 42.86%	10,000 $1.77 Million
Q1 2022 May 09, 2022	BUY	$119.61 - $157.85 $2.09 Million - $2.76 Million	17,500 New	17,500 $2.52 Million
Q4 2021 Feb 08, 2022	SELL	$142.57 - $190.86 $5.56 Million - $7.44 Million	-39,000 Closed	0 $0

Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $2.71 Million - $3.23 Million	19,000 Added 95.0%	39,000 $10.3 Million
Q2 2021 Aug 10, 2021	BUY	$135.08 - $161.1 $2.7 Million - $3.22 Million	20,000 New	20,000 $3.16 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.